Last deal

$8M

Amount

Venture - Series Unknown

Stage

27.09.2018

Date

5

all rounds

$20.3M

Total amount

General

About Company
Axion Biosystems develops technologies that solve problems related to human heart and brain activity.

Industry

Sector :

Subsector :

Also Known As

Axion

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The Atlanta-based life science company offers Microelectrode Arrays (MEA) and impedance technologies to understand cell behavior and function in real-time. Their suite of live-cell analysis tools provides continuous, noninvasive monitoring of in vitro cell models, accelerating scientific breakthroughs and transforming therapeutic development from discovery to manufacturing. Axion Biosystems' innovative, industry-leading products increase throughput, functionality, and information for biomedical researchers to improve their research and research process for drug discovery and disease modeling. With over 180 employees worldwide, the company promotes a culture of collaboration, innovation, inclusivity, and customer commitment.
Contacts